What is the primary purpose of this investment in Cellebrite?

The primary purpose of this $90 million investment is to deepen Axon's strategic relationship with Cellebrite and strengthen its integrated digital evidence management ecosystem. It follows a prior partnership aimed at combining their platforms for law enforcement, and this investment signals Axon's commitment to this combined offering.

Is this investment in Cellebrite guaranteed to close?

No, the investment is not guaranteed. It is contingent upon customary closing conditions, but most importantly, it requires the successful consummation of Cellebrite's business combination with TWC Tech Holdings II Corp., a publicly traded special purpose acquisition company (SPAC).

How does this investment benefit Axon's existing business?

This investment enhances Axon's ability to offer a more comprehensive solution for law enforcement by integrating Cellebrite's digital intelligence capabilities into its ecosystem. Given the significant customer overlap and complementary nature of their solutions, this partnership and investment aim to create a more robust and unified platform for managing digital evidence and investigations, potentially increasing customer stickiness and market competitiveness.

What is Cellebrite's role in this agreement?

Cellebrite DI Ltd. is a market leader in digital investigations and digital intelligence platforms. In this agreement, they are selling 9,000,000 shares of their common stock to Axon as part of a larger business combination with TWC Tech Holdings II Corp. Their technology is key to the integrated solution Axon is developing.

AXON 8-K: Material Agreements

Summary

On April 8, 2021, Axon Enterprise, Inc. (AXON) announced a significant strategic investment in Cellebrite DI Ltd., a leader in digital intelligence solutions. Axon entered into a Share Purchase Agreement to acquire 9,000,000 shares of Cellebrite common stock for an aggregate purchase price of $90 million. This investment is contingent upon the successful completion of Cellebrite's business combination with TWC Tech Holdings II Corp., a SPAC. This move deepens the existing partnership between Axon and Cellebrite, which was initially announced in February 2021. The prior agreement focused on integrating Cellebrite's Digital Intelligence platform with Axon's Axon Evidence solution, aiming to provide law enforcement with a unified platform for managing digital evidence. The financial investment signifies Axon's commitment to this integrated ecosystem, leveraging Cellebrite's market leadership and customer overlap to enhance its public safety offerings.

Key Highlights

1Axon investing $90 million to purchase 9 million shares of Cellebrite DI Ltd. common stock.
2The investment is contingent on the consummation of Cellebrite's business combination with TWC Tech Holdings II Corp. (a SPAC).
3This follows a strategic partnership announced in February 2021 for data integration between Cellebrite's platform and Axon Evidence.
4The investment strengthens Axon's commitment to a unified digital evidence management ecosystem for law enforcement.
5Cellebrite is identified as a market leader in digital investigations with significant customer overlap with Axon.
6The transaction is structured as a share purchase at $10.00 per share.

AXON ENTERPRISE, INC. 8-K Report, Material Agreement (Apr 8, 2021)

Summary

Key Highlights

Frequently Asked Questions